Novo Nordisk stock jumped Friday after the Danish drugmaker announced new data for a new weight-loss drug which appeared to ...

KEY TAKEAWAYS Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage ...

The Dow Jones Industrial Average certainly has some overlap with the other headline stock market indexes. Click here to read ...

Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Ford Motor Company (F) shares are under pressure following a downgrade from Barclays (BCS). The investment firm lowered its ...

The Nasdaq Composite is an often-cited stock market index — along with the S&P 500 and the Dow Jones Industrial Average — ...

Novo Nordisk's amycretin trial results highlight significant weight loss in adults with obesity, with further clinical ...

The optimism surrounding U.S. equity markets is understandable, yet no trend lasts forever. Diversification remains the only ...

On Friday, however, Novo Nordisk announced top-line results in yet another trial. While the results don't initially sound as ...

U.S. stocks recovered some ground Tuesday morning after getting hammered by fears over China's DeepSeek AI model built on a ...

DT Midstream Inc (DTM) stock saw a decline, ending the day at $97.52 which represents a decrease of $-13.89 or -12.47% from the prior close of $111.41. The stock opened at $108.5 and touched a low of ...